A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation
Clinical trial NCT03608501 · WITHDRAWN
Trial details
- NCT number
- NCT03608501
- Sponsor
- Takeda
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2021-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.